Primus-e Mullis

Bern, BE 3010, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing.

Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing.

Journal: Endocrinology
Published: June 03, 2016

Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II.

Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II.

Journal: Biochemical pharmacology
Published: June 02, 2016

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.

Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.

Journal: The Journal of clinical endocrinology and metabolism
Published: May 04, 2016

IGHD II: A Novel GH-1 Gene Mutation (GH-L76P) Severely Affects GH Folding, Stability, and Secretion.

IGHD II: A Novel GH-1 Gene Mutation (GH-L76P) Severely Affects GH Folding, Stability, and Secretion.

Journal: The Journal of clinical endocrinology and metabolism
Published: October 21, 2015

A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study.

A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study.

Journal: Clinical endocrinology
Published: June 19, 2015

Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Journal: Hormone research in paediatrics
Published: February 04, 2015

Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43.

Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43.

Journal: PloS one
Published: June 18, 2014

Alteration of ZnT5-mediated zinc import into the early secretory pathway affects the secretion of growth hormone from rat pituitary cells.

Alteration of ZnT5-mediated zinc import into the early secretory pathway affects the secretion of growth hormone from rat pituitary cells.

Journal: Hormone research in paediatrics
Published: March 24, 2014

Heterozygous GHR gene mutation in a child with idiopathic short stature.

Heterozygous GHR gene mutation in a child with idiopathic short stature.

Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: September 04, 2013

Isolated growth hormone deficiency type 2: from gene to therapy.

Isolated growth hormone deficiency type 2: from gene to therapy.

Journal: Endocrine development
Published: November 28, 2012

From endoplasmic reticulum to secretory granules: role of zinc in the secretory pathway of growth hormone.

From endoplasmic reticulum to secretory granules: role of zinc in the secretory pathway of growth hormone.

Journal: Endocrine development
Published: November 28, 2012

Preface: developmental biology of growth hormone (GH) secretion.

Preface: developmental biology of growth hormone (GH) secretion.

Journal: Endocrine development
Published: November 28, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026